Note: Ingredients listed on restricted chemical lists
EC/CAS
205-088-6/133-07-3
Name of the chemical
N-(Trichloromethylthio)phthalimide
Concentration
50
EC/CAS
202-905-8/100-97-0
Name of the chemical
Hexamethylenetetramine
Concentration
0-1
General Information
Version
1.0/IE (eng
Revision date
2022-12-19
Product name
KINGMAN
Emergency telephone
+353 1 809 2566, +353 1 809 2166
Icons in SDS
Company Information
company name
Sharda Cropchem Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
regn@shardaintl.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H351, H400, H410
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
No additional information available
2.2 Label elements
Labelling
Hazard pictograms
GHS07 GHS08 GHS09
Signal word
Warning
Contains
folpet (ISO); N-(trichloromethylthio)phthalimide
Hazard statements
H317 - May cause an allergic skin reaction. H351 - Suspected of causing cancer. H410 - Very toxic to aquatic life with long lasting effects.
Precautionary statements
P102 - Keep out of reach of children. P201 - Obtain special instructions before use. P280 - Wear protective gloves/protective clothing/eye protection/face protection. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
Supplemental label elements
EUH208 - Contains folpet (ISO); N-(trichloromethylthio)phthalimide(133-07-3), methenamine; hexamethylenetetramine(100-97-0). May produce an allergic reaction. EUH401 - To avoid risks to human health and the environment, comply with the instructions for use.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605.